CYTOMEGALOVIRUS INFECTION

Clinical trials for CYTOMEGALOVIRUS INFECTION explained in plain language.

Never miss a new study

Get alerted when new CYTOMEGALOVIRUS INFECTION trials appear

Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 2 Not yet finished but already full! 3 Completed 4 Terminated 1

New mRNA vaccine aimed at preventing common but risky virus

⭐️ VACCINE ⭐️ Terminated

This phase 3 trial tested an mRNA vaccine (mRNA-1647) to prevent cytomegalovirus (CMV) infection in healthy people aged 16 to 40. The study enrolled over 7,400 participants, focusing on women who had never been infected with CMV. The vaccine aims to trigger an immune response to …

Matched conditions: CYTOMEGALOVIRUS INFECTION

Phase: PHASE3 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 08:04 UTC

CYTOMEGALOVIRUS INFECTION

Get alerted when new CYTOMEGALOVIRUS INFECTION trials appear

New mRNA vaccine aimed at preventing common but risky virus